Opendata, web and dolomites

SELNET SIGNED

Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SELNET project word cloud

Explore the words cloud of the SELNET project. It provides you a very rough idea of what is the project "SELNET" about.

brazil    death    data    deaths    adult    pathologists    soft    scarcity    prognosis    10    diagnosis    drivers    rica    healthcare    unavailability    30    countries    hindered    network    referral    cancers    cpgs    caribbean    malignancies    heterogeneous    centers    therapies    poor    absence    multidisciplinary    improvement    selnet    education    care    worsen    diagnoses    international    groups    boards    rcs    cancer    prognostic    threatening    group    networks    relapse    clinical    hence    replicable    expertise    mexico    solid    validating    models    creation    incorrect    model    american    patient    conduct    cancersrare    biobanks    tissues    community    translational    core    sarcomas    trials    collaborative    representing    observational    bone    argentina    costa    preclinical    incidence    financial    spain    survival    registry    subtypes    medical    expert    intercontinental    celac    reference    rare    accounting       barrier    sarcoma    specialists    drugs    adherence    tumors    italy    mtbs    delayed    22    create    france    appropriate    lack    patients    life    complete    tumor    guidelines    latin    policies    quality    practitioners    pathological    peru    strategic    risk   

Project "SELNET" data sheet

The following table provides information about the project.

Coordinator
SERVICIO ANDALUZ DE SALUD 

Organization address
address: AVENIDA DE LA CONSTITUCION 18
city: SEVILLA
postcode: 41071
website: http://www.sas.junta-andalucia.es/principal/default.asp

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 3˙294˙306 €
 EC max contribution 3˙092˙400 € (94%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SC1-2018-Single-Stage-RTD
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SERVICIO ANDALUZ DE SALUD ES (SEVILLA) coordinator 792˙000.00
2    CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD FR (LYON) participant 486˙000.00
3    FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI IT (Milan) participant 450˙000.00
4    ISTITUTO ORTOPEDICO RIZZOLI IT (BOLOGNA) participant 432˙000.00
5    GRUPO ESPANOL DE INVESTIGACION EN SARCOMAS ASOCIACION ES (MADRID) participant 306˙000.00
6    ALEXANDER FLEMING SA AR (BUENOS AIRES) participant 194˙400.00
7    FUNDACION AMOR ESPERANZA Y VIDA CR (HEREDIA) participant 180˙000.00
8    INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-INEN PE (LIMA) participant 176˙400.00
9    SARCOMA PATIENTS EURONET EV DE (WOLFERSHEIM) participant 75˙600.00
10    FUNDACAO ANTONIO PRUDENTE BR (SAO PAULO) participant 0.00
11    Instituto Nacional de Cancerología MX (MEXICO) participant 0.00

Map

 Project objective

Rare cancersRare cancers are associated with poor survival, accounting for 22% of new cancer diagnoses in Europe, and 30% of cancer deaths. Sarcomas are a heterogeneous group of life-threatening rare solid malignancies affecting soft and bone tissues, representing 10% of rare tumors and around 2% of adult tumors, with an incidence of 5.9/100,000/year in Europe. Appropriate management of sarcoma patients is hindered by the absence of referral policies to reference centers (RCs), incorrect or delayed diagnosis, non-adherence of therapies to clinical practice guidelines (CPGs), and lack of expertise by practitioners, which increases the risk of relapse and death. These problems worsen in the Community of Latin American and Caribbean States (CELAC) due to the scarcity or complete unavailability of RCs, expert pathologists, multidisciplinary tumor boards (MTBs), new cancer drugs, clinical trials, patient registry data, and financial resources. Hence, the SELNET project seeks to create a European and Latin American multidisciplinary network of clinical and translational specialists to improve diagnosis and clinical care in sarcomas, with the aim of validating a collaborative model replicable in other rare tumors and in other countries. Recognized cancer centers and research groups of Spain, Italy, France, Mexico, Brazil, Argentina, Costa Rica, and Peru will contribute to better rare cancer care by fostering RCs, healthcare barrier analysis, CPGs, and medical education as key improvement drivers. The core of the research work focuses on improving diagnosis and prognosis of sarcoma patients through the creation of pathological diagnosis networks, MTBs, the conduct of an international registry-based observational study to assess clinical management quality and prognostic factors, and the implementation of an strategic translational research program to develop intercontinental sarcoma biobanks, preclinical models, and a translational study with drugs in rare sarcoma subtypes.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SELNET" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SELNET" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

VANGUARD (2020)

New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

AutoCRAT (2020)

Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis

Read More